    <SEC-DOCUMENT>0001193125-26-137931-index.html : 20260401
    <SEC-HEADER>0001193125-26-137931.hdr.sgml : 20260401
    <ACCEPTANCE-DATETIME>20260401161627
    ACCESSION NUMBER:		0001193125-26-137931
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20251231
    FILED AS OF DATE:		20260401
    DATE AS OF CHANGE:		20260401
    EFFECTIVENESS DATE:		20260401

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Viking Therapeutics, Inc.
    		CENTRAL INDEX KEY:			0001607678
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		EIN:				461073877
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-37355
    		FILM NUMBER:		26828437

    	BUSINESS ADDRESS:
    		STREET 1:		9920 PACIFIC HEIGHTS BLVD, SUITE 350
    		CITY:			SAN DIEGO
    		STATE:			CA
    		ZIP:			92121
    		BUSINESS PHONE:		858-704-4660

    	MAIL ADDRESS:
    		STREET 1:		9920 PACIFIC HEIGHTS BLVD, SUITE 350
    		CITY:			SAN DIEGO
    		STATE:			CA
    		ZIP:			92121
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>vktx-2026-04-01-ars.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: vktx-2026-04-01-ars.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>